The Wall Street Journal has the numbers.
Pfizer: John LaMattina [Research Chief] left the company last year after the failure of their cholesteral drug torcetrapib. "His exit package was worth:
$22.6 Million."
Pfizer: David Shedlarz [former CEO] "His exit package was worth:
$34.2 Million."
Merck: Dick Clark [CEO] whose compensation package for 2007 was:
$19.9 Million
Wyeth: Robert Essner [CEO] grabbed $32.9 Million in 2006 and in 2007:
$24.1 Million
Abbot: Miles White [CEO] in 2007 grabbed himself a package worth:
$33.4 Million
Bristol Myers Squibb: James Cornelius [CEO] grabbed himself:
$11.3 Million
Johnson & Johnson: William Weldon [CEO] as reported already, grabbed:
$31.9 Million
Pfizer: Geodon
Bristol Myers Squibb: Abilify
Wyeth: Effexor
Johnson & Johnson: Risperdal
Geodon, Abilify and Risperdal are atypical antipsychotics.
Effexor is advertised for the Treatment of 'Social Anxiety Disorder'.
Andrea Yates was 'Treated' with Effexor and Risperdal.
No comments:
Post a Comment